The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.
about
The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor bindingGDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cellsRegulation of myostatin activity and muscle growthRecombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agentPulmonary fibrosis: pathogenesis, etiology and regulationAutocrine expression of activated transforming growth factor-beta(1) induces apoptosis in normal rat liver.Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta.Hepatic deletion of Smad7 in mouse leads to spontaneous liver dysfunction and aggravates alcoholic liver injury.Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex.Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.Latency-associated peptide of transforming growth factor beta enhances mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 miceBiology of transforming growth factor beta in hepatocarcinogenesis.Cytosolic phospholipase A2alpha and peroxisome proliferator-activated receptor gamma signaling pathway counteracts transforming growth factor beta-mediated inhibition of primary and transformed hepatocyte growthTissue stretch decreases soluble TGF-beta1 and type-1 procollagen in mouse subcutaneous connective tissue: evidence from ex vivo and in vivo models.Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.Development of novel activin-targeted therapeutics.A mechanism of repression of TGFbeta/ Smad signaling by oncogenic RasMT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signalingRole of elevated plasma transforming growth factor-beta1 levels in wound healing.Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.Identification and characterization of canine growth differentiation factor-9 and its splicing variant.Transforming growth factor beta contributes to progressive diabetic nephropathyIn vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta.A molecular view of liver regeneration.Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.Accumulation of exogenous activated TGF-β in the superficial zone of articular cartilage.Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney diseaseTGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation.Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1Cell-matrix interactions in muscle disease.Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression.Activin, neutrophils, and inflammation: just coincidence?Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis.Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells.A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligandsThe pro-peptide of proNGF: structure formation and intramolecular association with NGF.
P2860
Q24321603-994DD907-AE20-4F30-83FF-592503C544B1Q24531973-AE57BF26-CD9A-4ADD-9075-064033DE8864Q24555817-2955BC02-3D5A-4F16-8297-1B9582D3528DQ28360679-F3E23E01-7D3F-4384-96D2-1C6B05E1124AQ28388425-DD3CBDCA-FDD2-4151-92CF-D743873A7112Q31721830-836D9ADB-72A1-461E-B36D-96FC2A1CCC72Q33637210-AD6B2A54-EC5C-4EF2-8A31-FD076D7FE19BQ33840844-6500A4C7-379D-4083-8CF8-BBC501A702F0Q33883297-C22D794C-D3E5-41CE-BFD3-94BCAE8B41D7Q33886619-888C44EA-2DE3-4108-8256-E16E394B8ECDQ34005085-65D5801C-CE7B-445E-BD7E-09CE181176FDQ34136515-36E2D78C-C2C8-4302-ACF4-D309869A2925Q34455310-7EA25757-AC5E-489D-8FDD-C68F1E75393DQ34729690-1AA9CD7E-3286-409C-B0EE-41B89074A21DQ34994545-43FBCE61-5444-4746-8C60-3352E78537C7Q35153096-E9B359B4-61E5-4A62-9EB1-7185D671F9DBQ35193411-F8AC1F5A-6CE4-4E4C-8870-9CE0B3A50F67Q35388201-59D8B564-1AC9-4D18-884E-B989C32D081BQ35786858-DB0523DF-32E2-4797-9F8C-85CB476238E9Q35861493-23CE9050-B28B-4D61-968B-B76124311DE9Q36010170-18550487-E11E-4AA1-94D4-EFA915149074Q36102963-CA2A565C-A476-4F83-85D1-20A43935AF0AQ36107522-28B3100A-E6B7-4CAA-8183-680D8C286808Q36609489-399D9249-1D23-4EE8-9894-A2888FA0F876Q36674035-381A53D5-6513-47E1-9E86-31EB163859EEQ36770447-43F0CB0F-1ED5-4095-888A-F6BFE8F4AC82Q36785571-171D35A4-7C6D-4A1C-9113-8BA03435BE7FQ36807057-DC570D9B-C428-460B-8D5B-6CAAA607E8B3Q37169070-6FEA0AA0-4D2F-4022-BBDD-CE2D7A7830AAQ37272232-D8F4415B-08CF-4D29-8911-F1F11DCDDA7BQ37352517-B54C39DD-EE08-4141-92AB-B52DE088ED89Q37944530-882F9228-73B8-481F-9D52-4FF01B807062Q37970379-D3D9003D-30BB-4B97-B3C9-34C5AE51DB0CQ38079493-B708C09E-9976-4C91-A7E6-0F1988D9072CQ38362396-4550DF37-0ACA-40B9-96E8-5C3B708BE7C5Q40456120-4F66E7D1-819E-4970-B6A5-2CFEB7227BC1Q41010363-D5CD23AC-D02C-42FF-B514-B4DB8FDDC964Q41089111-7801D14D-9A0E-4F4D-9A7C-3A44EF7367E6Q41991001-D3711BFE-DEC6-46E1-8D29-E843145733D5Q42098632-4E83D1A8-C3E7-4C45-8EA2-BA7B805AB367
P2860
The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The recombinant proregion of t ...... ctor beta1 in transgenic mice.
@en
The recombinant proregion of transforming growth factor beta1
@nl
type
label
The recombinant proregion of t ...... ctor beta1 in transgenic mice.
@en
The recombinant proregion of transforming growth factor beta1
@nl
prefLabel
The recombinant proregion of t ...... ctor beta1 in transgenic mice.
@en
The recombinant proregion of transforming growth factor beta1
@nl
P2093
P2860
P356
P1476
The recombinant proregion of t ...... actor beta1 in transgenic mice
@en
P2093
A B Roberts
E P Böttinger
J A Weatherbee
S S Thorgeirsson
V M Factor
P2860
P304
P356
10.1073/PNAS.93.12.5877
P407
P577
1996-06-01T00:00:00Z